Wednesday, July 23, 2014 12:08:10 PM
"I am pleased to accept the organizers' offer to present at #C4CT," said Dr. Arendt. After being the first to identify the scientific principles underpinning Amarantus' diagnostic blood test LymPro[color=red][/color], I have continued my research into Alzheimer's disease with a strong focus on human tissue evaluation from Alzheimer's patients. Ibelieve there is a need to take a much broader perspective in thinking about Alzheimer's, and I am pleased to have this unique forum to share my perspective with the world."
In addition to Gerald being given time to present, I think giving Dr. Arendt 30 minutes means LymPro's break through data is going to be highlighted at the Conference!! That's huge!!
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM